Organization: Health Canada
Year: 2024
Month: October
Request Number: A-2024-000496
Request Summary: The most current status of the Abbreviated New Drug Submission (ANDS) seeking approval of a generic degarelix acetate product, which was accepted into review by Health Canada in January 2024: Inactive; Process; Process Hold; Withdrawn. If the status of the degarelix acetate ANDS is otherwise, please advise.
Disposition: All disclosed
Number of pages: 1